MAHLY
Price
$18.34
Change
+$0.84 (+4.80%)
Updated
Sep 15 closing price
Capitalization
3.51B
MEPDF
Price
$15.90
Change
-$0.35 (-2.15%)
Updated
Jul 7 closing price
Capitalization
3.51B
Interact to see
Advertisement

MAHLY vs MEPDF

Header iconMAHLY vs MEPDF Comparison
Open Charts MAHLY vs MEPDFBanner chart's image
Medipal Holdings
Price$18.34
Change+$0.84 (+4.80%)
Volume$146
Capitalization3.51B
Medipal Holdings
Price$15.90
Change-$0.35 (-2.15%)
Volume$100
Capitalization3.51B
MAHLY vs MEPDF Comparison Chart in %
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MAHLY vs. MEPDF commentary
Oct 04, 2025

To understand the difference between Medipal Holdings Corporation - ADR (MAHLY) vs. Medipal Holdings Corporation (MEPDF) it is enough to know the definitions of ADR

ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 04, 2025
Stock price -- (MAHLY: $18.34 vs. MEPDF: $15.90)
Brand notoriety: MAHLY and MEPDF are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: MAHLY: 49% vs. MEPDF: 100%
Market capitalization -- MAHLY: $3.51B vs. MEPDF: $3.51B
MAHLY [@Medical Distributors] is valued at $3.51B. MEPDF’s [@Medical Distributors] market capitalization is $3.51B. The market cap for tickers in the [@Medical Distributors] industry ranges from $94.37B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MAHLY’s FA Score shows that 1 FA rating(s) are green whileMEPDF’s FA Score has 1 green FA rating(s).

  • MAHLY’s FA Score: 1 green, 4 red.
  • MEPDF’s FA Score: 1 green, 4 red.
According to our system of comparison, MAHLY is a better buy in the long-term than MEPDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MAHLY’s TA Score shows that 2 TA indicator(s) are bullish.

  • MAHLY’s TA Score: 2 bullish, 2 bearish.

Price Growth

MAHLY (@Medical Distributors) experienced а 0.00% price change this week, while MEPDF (@Medical Distributors) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -0.84%. For the same industry, the average monthly price growth was +0.34%, and the average quarterly price growth was +9.11%.

Industries' Descriptions

@Medical Distributors (-0.84% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MAHLY($3.51B) and MEPDF($3.51B) have the same market capitalization . MAHLY has higher P/E ratio than MEPDF: MAHLY (14.05) vs MEPDF (12.18). MEPDF YTD gains are higher at: 20.091 vs. MAHLY (14.090). MAHLY (100B) and MEPDF (100B) have comparable annual earnings (EBITDA) . MAHLY (251B) and MEPDF (251B) have equal amount of cash in the bank . MAHLY (3.6T) and MEPDF (3.6T) have equivalent revenues.
MAHLYMEPDFMAHLY / MEPDF
Capitalization3.51B3.51B100%
EBITDA100B100B100%
Gain YTD14.09020.09170%
P/E Ratio14.0512.18115%
Revenue3.6T3.6T100%
Total Cash251B251B100%
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
MAHLY vs MEPDF: Fundamental Ratings
MAHLY
MEPDF
OUTLOOK RATING
1..100
4740
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
9351
SMR RATING
1..100
5252
PRICE GROWTH RATING
1..100
4957
P/E GROWTH RATING
1..100
2122
SEASONALITY SCORE
1..100
9045

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MEPDF's Valuation (88) in the null industry is in the same range as MAHLY (91). This means that MEPDF’s stock grew similarly to MAHLY’s over the last 12 months.

MEPDF's Profit vs Risk Rating (51) in the null industry is somewhat better than the same rating for MAHLY (93). This means that MEPDF’s stock grew somewhat faster than MAHLY’s over the last 12 months.

MEPDF's SMR Rating (52) in the null industry is in the same range as MAHLY (52). This means that MEPDF’s stock grew similarly to MAHLY’s over the last 12 months.

MAHLY's Price Growth Rating (49) in the null industry is in the same range as MEPDF (57). This means that MAHLY’s stock grew similarly to MEPDF’s over the last 12 months.

MAHLY's P/E Growth Rating (21) in the null industry is in the same range as MEPDF (22). This means that MAHLY’s stock grew similarly to MEPDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MAHLYMEPDF
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
34%
N/A
Momentum
ODDS (%)
Bullish Trend 4 days ago
44%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
37%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
36%
Bullish Trend 2 days ago
15%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
36%
Bullish Trend 2 days ago
13%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFECX136.23N/A
N/A
MFS Growth C
PRECX19.97N/A
N/A
PGIM Jennison Blend C
RGWCX25.78N/A
N/A
Victory RS Growth C
FWCFX36.27N/A
N/A
Fidelity Advisor Worldwide C
BVEIX22.48N/A
N/A
Becker Value Equity Institutional

MAHLY and

Correlation & Price change

A.I.dvisor tells us that MAHLY and ZYXI have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAHLY and ZYXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAHLY
1D Price
Change %
MAHLY100%
N/A
ZYXI - MAHLY
5%
Poorly correlated
+0.69%
PDRX - MAHLY
2%
Poorly correlated
N/A
SHPMF - MAHLY
2%
Poorly correlated
N/A
ARRJF - MAHLY
2%
Poorly correlated
-6.57%
COSM - MAHLY
2%
Poorly correlated
+0.91%
More

MEPDF and

Correlation & Price change

A.I.dvisor tells us that MEPDF and PDRX have been poorly correlated (+0% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEPDF and PDRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEPDF
1D Price
Change %
MEPDF100%
N/A
PDRX - MEPDF
0%
Poorly correlated
N/A
ARRJF - MEPDF
0%
Poorly correlated
-6.57%
MAHLY - MEPDF
0%
Poorly correlated
N/A
NSVGF - MEPDF
0%
Poorly correlated
N/A
COSM - MEPDF
-1%
Poorly correlated
+0.91%
More